Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com


  • Pretty weak financial results growth rate 5.2% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-3.2%)
  • Dividend yield for the last twelve months 0.3%
  • Free cash flow yield -19.7% (LTM)
  • Share price is 39.3% higher than minimum and 13.5% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (24.8x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $66.5 mln (-0.029% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (-0.6%)543.54
year average price 500.05  


year start price 545.23 2025-02-11

min close price 390.26 2025-06-17

max close price 628.18 2026-01-26

current price 546.48 2026-02-10
Common stocks: 391 000 000

Dividend Yield:  0.3%
FCF Yield LTM: -19.7%
EV / LTM EBITDA: 24.8x
EV / EBITDA annualized: 21.8x
Last revenue growth (y/y):  +4.9%
Last growth of EBITDA (y/y):  +5.5%
Historical revenue growth:  -0.2%
Historical growth of EBITDA:  -6.3%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 212 524
Net Debt ($m): 33 698
EV (Enterprise Value): 246 222
EBITDA LTM ($m): 9 933
EV / LTM EBITDA: 24.8x
Price to Book: 4.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-29seekingalpha.com

Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript

2026-01-29proactiveinvestors.com

Thermo Fisher stock slides on cautious profit guidance

2026-01-29zacks.com

Thermo Fisher's Q4 Earnings & Revenues Top Estimates, Stock Climbs

2026-01-29zacks.com

Thermo Fisher Scientific (TMO) Beats Q4 Earnings and Revenue Estimates

2026-01-29reuters.com

Thermo Fisher beats quarterly results estimates on demand for tools from pharma clients

2026-01-29businesswire.com

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results

2026-01-26zacks.com

Countdown to Thermo Fisher (TMO) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

2026-01-23zacks.com

Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings?

2026-01-22zacks.com

Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth

2026-01-13seekingalpha.com

Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data